Trump administration proposes rule to cap hospital outpatient drug cost pass-throughs

The proposed regulation aims to restrict hospitals from shifting drug costs to outpatient billing, with an implementation target of 2027. The impact on hospital revenue models and pharmaceutical pricing remains uncertain pending formal rulemaking and potential legal challenges.